Job Watch
EMBL: Administrative Assistant (Full or Part Time)
Competitive Salary:
EMBL:
ELIXIR is seeking an experienced Administrative Assistant to join the international team at the ELIXIR Hub in Hinxton, UK on either a full time or par
Hinxton, Cambridgeshire, England
Categories: Job Watch
EMBL: Research Support Officer
Competitive Salary:
EMBL:
EMBL's European Bioinformatics Institute (EMBL-EBI) is seeking a Research Support Officer to assist the Service Team Leaders leading EMBL-EBI’s resour
Hinxton, Cambridgeshire, England
Categories: Job Watch
EMBL: Postdoctoral Fellow - Bioinformatics
Competitive Salary:
EMBL:
The Steinmetz group at EMBL Heidelberg is looking for an ambitious computational fellow (postdoc or research scientist, depending on the level of expe
Germany (DE)
Categories: Job Watch
Administrative Supplements to Support Cancer Disparity Collaborative Research (Clinical Trial Optional)
Funding Opportunity PAR-22-114 from the NIH Guide for Grants and Contracts. The purpose of this trans-NCI Funding Opportunity Announcement (FOA) is to promote new cancer disparities research among investigators who do not normally conduct it and to encourage the partnership of experienced cancer research investigators with cancer disparities-focused researchers. This FOA is intended to accelerate and strengthen multi-disciplinary cancer disparities research in wide ranging areas. Cancer disparities research includes, but is not limited to basic, translational, behavioral, observational, interventional, environmental and population research studies that address the adverse differences in cancer incidence, prevalence, mortality, survivorship, burden and/or response to treatment in racial/ethnic minorities and/or underserved population groups. Proposed collaborations should focus on achieving research objectives that by necessity rely on diverse and complementary expertise, technical capabilities, and resource sets. Importantly, the supplemental request is required to be within the scope of the parent award and should expand the original aims to include a cancer disparity component and possible inclusion of international comparator cohorts. A trans NCI effort, the concept reissuance of the Collaborative Program is supported by NCIs Division of Cancer Biology (DCB), Division of Cancer Treatment and Diagnosis (DCTD), Division of Cancer Prevention (DCP), Division of Cancer Control and Population Sciences (DCCPS), Center to Reduce Cancer Health Disparities (CRCHD) and now, also included Center for Global Health.
Categories: Job Watch, Literature Watch
Notice of Special Interest (NOSI): CCRP Administrative Supplement for Collaborative Science to Synergize Chemical Medical Countermeasures Discovery and Early Development
Notice NOT-AI-22-029 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Special Interest (NOSI): Administrative Supplements for Complementary Health Practitioner Research Experience (Admin Supplements)
Notice NOT-AT-22-010 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Research Technologist II - Medical College of Wisconsin - Milwaukee, WI
Carry out routine and complex experiments and data analysis. Participate in the analysis of omics data. Participate in cell and molecular research as directed…
From Medical College of Wisconsin - Thu, 24 Feb 2022 21:14:04 GMT - View all Milwaukee, WI jobs
From Medical College of Wisconsin - Thu, 24 Feb 2022 21:14:04 GMT - View all Milwaukee, WI jobs
Categories: Job Watch
SRG: Senior Scientist - R&D - NGS
GBP42000.00 - GBP55000.00 per annum:
SRG:
R&D opportunity!
London, England
Categories: Job Watch
Immune Drivers of Autoimmune Disease (IDAD) (U01 Clinical Trial Not Allowed)
Funding Opportunity RFA-AI-22-012 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites applications to participate in the Immune Drivers of Autoimmune Disease (IDAD) cooperative research program, which will focus on defining the immunologic states and dynamics that drive autoimmune disease. The main objective of this program is to enhance our understanding of the immunologic processes, events, and changes that underlie the clinical manifestations of autoimmune diseases, including disease flare, remission, and progression of established disease, as well as the progression from a state of elevated risk to clinical diagnosis of autoimmune disease.
Categories: Job Watch, Literature Watch
Notice of Intent to Publish a Funding Opportunity Announcement for Emergency Awards: Biocontainment Facility Improvements and Building System Upgrades to Support Pandemic Preparedness (G20 Clinical Trial Not Allowed)
Notice NOT-AI-22-032 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Hyper Recruitment Solutions (HRS): Senior Software Engineer
£38000 - £45000 per annum:
Hyper Recruitment Solutions (HRS):
We are currently looking for a Senior Software Engineer to join a world-leading research organisation based in the Hertfordshire area. Conducting ground breaking research that...
Hertfordshire
Categories: Job Watch
Partnerships for Rapid Diagnostics and Phenotypic Antibacterial Susceptibility Testing for Bacteremia or Hospital Acquired Pneumonia (R01 Clinical Trial Not Allowed)
Funding Opportunity RFA-AI-22-010 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to solicit research applications for projects focused on development and/or production of medical diagnostics that permit rapid differential species identification, and corresponding phenotypic antibacterial susceptibility profiles for bacteremia or hospital acquired pneumonia. The primary goal of such diagnostics is to facilitate antibacterial stewardship, thereby reducing selective pressure and improving patient outcomes.
Categories: Job Watch, Literature Watch
The Francis Crick Institute: Project Manager-Advanced Sequencing Facility
From £48,000 per annum, subject to skills and experience:
The Francis Crick Institute:
We are recruiting for a Project Manager- Advanced Sequencing Facility
London (Central), London (Greater) (GB)
Categories: Job Watch
Notice of Intent to Publish a Funding Opportunity Announcement for Clinical Trial Readiness for Rare Neurological and Neuromuscular Diseases (U01 Clinical Trial Not Allowed)
Notice NOT-NS-22-083 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Special Interest (NOSI): Epidemiology of Drug Abuse
Notice NOT-DA-22-004 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Maximizing the Scientific Value of the NHLBI Biologic Biospecimen Repository: Scientific Opportunities for Exploratory Research (R21)
Funding Opportunity RFA-HL-23-018 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) will support meritorious exploratory research relevant to the NHLBI mission (http://www.nhlbi.nih.gov/about/org/mission) using the existing biospecimen collections that are stored in the NHLBI Biologic Specimen Repository (Biorepository), thereby maximizing the scientific value of the stored collections and providing researchers with an opportunity to generate preliminary data for subsequent research proposals.
Categories: Job Watch, Literature Watch
Development of Biomarkers or Biomarker Signatures for Neurological and Neuromuscular Disorders (R61/R33 Clinical Trial Optional)
Funding Opportunity PAR-22-089 from the NIH Guide for Grants and Contracts. The overarching purpose of this Funding Opportunity Announcement (FOA) is to promote the discovery and/or early evaluation of strong candidate biomarkers and biomarker signatures that can be used as tools to facilitate the clinical development of neurotherapeutics and their use in clinical practice. Specifically, the focus of this FOA is on the identification and initial biological, analytical and clinical evaluation of biomarkers and biomarker signatures for neurological and neuromuscular disorders. Although research supported by this FOA can include animal studies, it must also include preliminary human evaluation using carefully standardized human samples or datasets. The goal of this initiative is to deliver candidate biomarkers or biomarker signatures that are ready for definitive analytical and clinical validation studies.
Categories: Job Watch, Literature Watch
Screening for Cognitive Impairment: Decision-Making (U24 Clinical Trial Optional)
Funding Opportunity RFA-AG-23-007 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites research to develop, validate, and disseminate measurement tools that could be used to screen for deficits related to decision-making, planning, and other important higher order functional outcomes in older adults. In particular, we are interested in instruments that can track changes in decision-making capacity that could be useful in the context of future screening for cognitive impairment and the development of interventions targeting functional outcomes in persons living with cognitive impairment and/or quality of life outcomes in their care partners/caregivers. The goal of the FOA is to support a research network whose goals would be to review and assess the dimensions of higher cognitive abilities and functional capacities already believed to support higher order planning and decision-making, to develop valid and reliable measures of those abilities, and to provide support for pilot efforts during the instrument development and validation in a racially, ethnically, geographically, and diagnostically diverse set of participants as well as a set of enduring resources including the measurement instruments, documentation, and normative data that will enable other, future projects to incorporate the new measurements into studies.
Categories: Job Watch, Literature Watch
Somatic Mosaicism across Human Tissues (SMaHT) Program: Genome Characterization Centers (UM1 Clinical Trial Not Allowed)
Funding Opportunity RFA-RM-22-013 from the NIH Guide for Grants and Contracts. This funding opportunity announcement invites applications to establish the Genome Characterization Centers (GCCs) for the Somatic Mosaicism across Human Tissues (SMaHT) Network. ?The purpose of the SMaHT Network is to enable discovery of new biology and disease mechanisms mediated by genomic variation in somatic tissues. The GCCs will be responsible for generating state of the art, high throughput genomic data characterizing somatic variants in a set of 10-15 human tissues from 150+ donors. The GCCs will work closely with the SMaHT Data Analysis Center to build the framework for a comprehensive catalog of variants.
Categories: Job Watch, Literature Watch
Somatic Mosaicism across Human Tissues (SMaHT) Program: Tissue Procurement Center (U24 Clinical Trial Not Allowed)
Funding Opportunity RFA-RM-22-012 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites applications to establish the Tissue Procurement Center for the Somatic Mosaicism across Human Tissues (SMaHT) Network.?The purpose of the SMaHT Network is to enable discovery of new biology and disease mechanisms mediated by genomic variation in somatic tissues. The goal of the Tissue Procurement Center is to collect, process, store, and rapidly distribute to the Network at least 15 high quality, well characterized, human tissues recovered from a minimum of 150 individuals recruited from a diverse pool of donors.
Categories: Job Watch, Literature Watch
Pages
